Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

Myogen

Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics.

Acquired by Gilead Sciences on October 02, 2006

Website: https://www.myogen.com

Founded: January 01, 1996

Social:

Add Competitor

Startup	Industry	Description
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
Telefarmacia App	Pharmaceuticals & Biotechnology	You don't have to go to the pharmacy anymore. - We serve the patient and the pharmacist, so that s ...
LabLog	Pharmaceuticals & Biotechnology	Lab Notebook App For The Life Sciences Industry - LabLog is an FDA compliant Electronic Lab Notebook ...

View more competitors»

Date	Round	Amount	Investors
Aug 29, 2003	Series D	$ 40,000,000	CMEA Ventures Interwest Partners Sequel Venture Partners Pacific Rim Partners New Enterprise Associates Perseus-Soros Biopharmaceutical Fund Greenspring Associates
Jan 03, 2002	Series D	$ 14,000,000	Perseus-Soros Biopharmaceutical Fund China Development Industrial Bank (CDIB) Silicon Valley Bank
Aug 28, 2001	Series D	$ 52,400,000	Sequel Venture Partners Pacific Rim Partners New Enterprise Associates Interwest Partners CMEA Ventures Adams Street Partners

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
Eric N. Olson	Founder	Unknown to Unknown